RT Journal Article
SR Electronic
T1 Vaccine hesitancy strongly correlates with COVID-19 deaths underreporting
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.27.22271579
DO 10.1101/2022.02.27.22271579
A1 Adam Sobieszek
A1 Miriam Lipniacka
A1 Tomasz Lipniacki
YR 2022
UL http://medrxiv.org/content/early/2022/03/01/2022.02.27.22271579.abstract
AB Vaccine acceptance is a key factor in achieving high immunization coverage and reducing the death toll of COVID-19 pandemic. Analyzing data from Europe and Americas we demonstrated that vaccine hesitancy strongly correlates with underreporting of COVID-19 deaths and cases. This correlation cannot be explained by the differences in economic indexes: GDP and Gini coefficient (measure of income inequalities). There is no correlation of vaccination percentage and Gini coefficient and the correlation with GDP is decreasing in time. The most striking is the comparison of Eastern European and South American countries; the latter group of countries shows significantly higher vaccination percentage while having a lower or comparable GDP and higher Gini coefficient. The analysis suggests that timely and reliable information about the COVID-19 cases and the associated deaths plays a key role in achieving population-wide vaccine acceptance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Science Centre Poland OPUS, grant 2018/29/B/NZ2/00668Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript